CDT Equity (CDT) Shares Outstanding (Entity) (2021 - 2026)
Powered by 
Analysis
CDT Equity (CDT) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.34 Bn | 621.58 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 446.74 Bn | 440.17 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 357.89 Bn | 350.75 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 267.44 Bn | 259.75 Bn | 11.24 Bn | - |
| 5 | Pfizer | 156.55 Bn | 144.85 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.21 Bn | 44.83 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.85 Bn | 42.85 Bn | - | 214.24 Mn |
| 8 | Incyte | 24.63 Bn | 20.09 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.40 Bn | 18.74 Bn | 683.80 Mn | 42.68 Mn |
| 10 | CDT Equity | 183,351.66 | 183,351.66 | - | 631,080.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 631,080.00 |
| Mar 31, 2026 | 73,046.00 |
| Dec 31, 2025 | 3,330.00 |
| Sep 30, 2025 | 54,084.00 |
| Jun 30, 2025 | 13,794.00 |
| Mar 31, 2025 | 3,238.00 |
| Dec 31, 2024 | 3,383.00 |
| Sep 30, 2024 | 80,008.00 |
| Jun 30, 2024 | 61,670.00 |
| Mar 31, 2024 | 61,528.00 |
| Dec 31, 2023 | 61,528.00 |
| Sep 30, 2023 | 60,681.00 |
| Jun 30, 2023 | 53,858.00 |
| Mar 31, 2023 | 53,858.00 |
| Dec 31, 2022 | 13,221.00 |
| Sep 30, 2022 | 11,650.00 |
| Jun 30, 2022 | 11,650.00 |
| Mar 31, 2022 | 6,807.00 |
| Dec 31, 2021 | 3,383.00 |